Home » Research Summaries » Search Results

Archives: Research Summaries

Neuromyelitis optica spectrum disorders

Journal: Clinical Medicine Journal; March 1, 2019

Author(s): Saif Huda, Dan Whittam, Maneesh Bhojak, Jayne Chamberlain, Carmel Noonan, Anu Jacob and Rachel Kneen

A review of NMOSD

The prevalence of depression, anxiety, and sleep disturbances in patients with neuromyelitis optica spectrum disorders (NMOSD): A systematic review and meta-analysis

Journal: Multiple Sclerosis and Related Disorders; September 12, 2023

Author(s): Jianyi Liu, Xiaobo Zhang, Yi Zhong and Xianglin Liu

Prevalence of depression, anxiety, and sleep disturbances in a large group of NMOSD patients

Aligning payer and provider strategies with the latest evidence to optimize clinical outcomes for patients with neuromyelitis optica spectrum disorder

Journal: Journal of Managed Care & Specialty Pharmacy; December 1, 2022

Author(s): Dean M Wingerchuk, Brian G Weinshenker, Dana McCormick, Sasha Barron, Laura Simone and Larissa Jarzylo

Helping payers and treatment providers to understand and appropriately address the burden posed by NMOSD

Efficacy and Safety of Rituximab in Central Nervous System Demyelinating Disorders (Indian context)

Journal: Annals of Indian Academy of Neurology; January 11, 2022

Author(s): Varsha A Patil, Saurabh N Kamat, Jamshed A Lalkak and Bhim Singhal

Effectiveness and safety of rituximab in MS, NMOSD, and MOGAD

Long-term Effectiveness and Safety of Rituximab in Neuromyelitis Optica Spectrum Disorder and MOG Antibody Disease

Journal: Neurology; August 31, 2022

Author(s): Paula Barreras, Eleni S Vasileiou, Angeliki G Filippatou, Kathryn C Fitzgerald, Michael Levy, Carlos A Pardo, Scott D Newsome, Ellen M Mowry, Peter A Calabresi and Elias S Sotirchos

Long-term effectiveness and safety of Rituximab in NMOSD and MOGAD

Comparison of live and fixed cell-based assay performance: implications for the diagnosis of MOGAD in a low-middle income country

Journal: Frontiers in Immunology; August 29, 2023

Author(s): Lekha Pandit, Anitha D’Cunha, Chaithra Malli and Akshatha Sudhir

Comparison of two diagnostic tests for MOGAD in an Indian population

Association of Maintenance Intravenous Immunoglobulin With Prevention of Relapse in Adult Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease

Journal: JAMA Neurology; May 1, 2022

Author(s): John J Chen, Saif Huda, Yael Hacohen, Michael Levy, Itay Lotan, Adi Wilf-Yarkoni, Hadas Stiebel-Kalish, Mark A Hellmann, Elias S Sotirchos, Amanda D Henderson, Sean J Pittock, M Tariq Bhatti, Eric R Eggenberger, Marie Di Nome, Ho Jin Kim, Su-Hyun Kim, Albert Saiz, Friedemann Paul, Russell C Dale, Sudarshini Ramanathan, Jacqueline Palace, Valentina Camera, Maria Isabel Leite, Byron L Lam, Jeffrey L Bennett, Sara Mariotto, Dave Hodge, Bertrand Audoin, Elisabeth Maillart, Romain Deschamps, Julie Pique, Eoin P Flanagan and Romain Marignier

IVIG for relapse prevention in adult MOGAD patients

Long-term Outcomes of MOGAD without Chronic Steroid-sparing Immunotherapy: a Multicenter Retrospective Cohort (S40.008)

Journal: Neurology; April 25, 2023

Author(s): Nanthaya Tisavipat, Adi Wilf-Yarkoni, Eoin Flanagan, Vyanka Redenbaugh, Yoel Schwartzmann, Mark Hellmann, Assaf Tolkovsky, Hadas Stiebel-Kalish, Itay Lotan, Michael Levy, Rebecca Salky, Adi Vaknin-Dembinsky, Esther Ganelin-Cohen, Alfonso Lopez, Sean Pittock and John Chen

Long-term outcomes in MOGAD patients not receiving any immunotherapy apart from steroids

Intravenous immunoglobulin treatment for acute attacks in myelin oligodendrocyte glycoprotein antibody disease

Journal: Multiple Sclerosis Journal; July 10, 2023

Author(s): Itay Lotan, John J Chen, Yael Hacohen, Omar Abdel-Mannan, Sara Mariotto, Saif Huda, Emily Gibbons, Adi Wilf-Yarkoni, Mark A Hellmann, Hadas Stiebel-Kalish, Sean J Pittock, Eoin P Flanagan, Negar Molazadeh, Monique Anderson, Rebecca Salky, Gabriela Romanow, Patrick Schindler, Ankelien Solveig Duchow, Friedemann Paul and Michael Levy

Effectiveness of IVIG treatment for acute attacks in MOGAD

The treatment of myelin oligodendrocyte glycoprotein antibody disease: a state-of-the-art review

Journal: Journal of Neuro-Ophthalmology; September 1, 2022

Author(s): Bart K. Chwalisz and Michael Levy

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.